Hep Par 1 and polyclonal CEA have low sensitivity (∼ 50%) for the diagnosis of poorly differentiated hepatocellular carcinoma. 3, 4 Hence, they may not be helpful in the setting of a poorly ...

Investigators examined medical records spanning 3 decades to look at the effect of poorly differentiated tumor size on outcomes in survival in hepatocellular carcinoma (HCC).

Hepatocellular carcinoma (HCC) is the most frequent primary tumor of the liver in adults. It accounts for up to 5.6% of all human cancers (7.5% among men and 3.5% among women).

Hepatocellular carcinoma (HCC) ... Lanzafame, M. et al. High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models.

Using information from 1,107 patients dating back 30 years, Osaka City University shows that overall survival of hepatocellular carcinoma decreases as poorly differentiated tumor size increases ...

Kogure et al. Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma. World Journal of Gastroenterology , 2009; 15 (10 ...

Background and Aim: This study investigated the clinical features of hepatocellular carcinoma in patients with sustained virological response to interferon for hepatitis C viral (HCV) infection ...

Patients with congenital heart disease who undergo the Fontan procedure may represent a novel group for screening for liver disease. Surveillance for hepatocellular carcinoma may be needed in such ...